323 related articles for article (PubMed ID: 25725765)
41. Incidence of neonatal hyperphenylalaninemia in fars province, South iran.
Karamifar H; Ordoei M; Karamizadeh Z; Amirhakimi GH
Iran J Pediatr; 2010 Jun; 20(2):216-20. PubMed ID: 23056707
[TBL] [Abstract][Full Text] [Related]
42. A survey for the incidence of phenylketonuria in Guangdong, China.
Jiang J; Ma X; Huang X; Pei X; Liu H; Tan Z; Zhu L
Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():185. PubMed ID: 15906732
[TBL] [Abstract][Full Text] [Related]
43. Assessment of tetrahydrobiopterin (BH4) responsiveness in phenylketonuria.
Fiege B; Blau N
J Pediatr; 2007 Jun; 150(6):627-30. PubMed ID: 17517248
[TBL] [Abstract][Full Text] [Related]
44. Discrimination of phenylketonurics from persistent hyperphenylalaninemia patients using a simple phenylalanine loading test.
Blitzer MG; Bailey-Wilson JE; Shapira E
Clin Chim Acta; 1985 Dec; 153(2):137-42. PubMed ID: 4064343
[TBL] [Abstract][Full Text] [Related]
45. DNAJC12 deficiency: A new strategy in the diagnosis of hyperphenylalaninemias.
Blau N; Martinez A; Hoffmann GF; Thöny B
Mol Genet Metab; 2018 Jan; 123(1):1-5. PubMed ID: 29174366
[TBL] [Abstract][Full Text] [Related]
46. Fifteen-year experience with screening for phenylketonuria with an automated fluorometric method.
Kirkman HN; Carroll CL; Moore EG; Matheson MS
Am J Hum Genet; 1982 Sep; 34(5):743-52. PubMed ID: 7124729
[TBL] [Abstract][Full Text] [Related]
47. Developmental delay and non-phenylketonuria (PKU) hyperphenylalaninemia in DNAJC12 deficiency: Case and approach.
Wong RSH; Mohammad S; Parayil Sankaran B; Junek R; Kim WT; Wotton T; Devanapalli B; Bandodkar S; Balasubramaniam S
Brain Dev; 2023 Oct; 45(9):523-531. PubMed ID: 37156708
[TBL] [Abstract][Full Text] [Related]
48. Phenylalanine hydroxylase deficiency.
Mitchell JJ; Trakadis YJ; Scriver CR
Genet Med; 2011 Aug; 13(8):697-707. PubMed ID: 21555948
[TBL] [Abstract][Full Text] [Related]
49. Phenylketonuria detected by the neonatal screening program in Thailand.
Pangkanon S; Ratrisawadi V; Charoensiriwatana W; Techasena W; Boonpuan K; Srisomsap C; Svasti J
Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():179-81. PubMed ID: 15906730
[TBL] [Abstract][Full Text] [Related]
50. Maternal hyperphenylalaninemias in healthy Czech population of pregnant women: 30 years experience with screening, prevention and treatment.
Hyanek J; Kozak L; Hrabincova E; Trnka V; Kobilkova J; Dolezal A; Soukup K; Zeman J; Stastna S; Vadurova L; Krijt J; Viletova H; Cervena M; Paterova T
Bratisl Lek Listy; 2004; 105(9):291-8. PubMed ID: 15633889
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of patients diagnosed with phenylketonuria and biotinidase deficiency by the newborn screening program: a ten-year retrospective study.
Toktaş İ; Sarıbaş S; Canpolat S; Erdem Ö; Özbek MN
Turk J Pediatr; 2022; 64(6):985-992. PubMed ID: 36583880
[TBL] [Abstract][Full Text] [Related]
52. Diagnostic and management practices for phenylketonuria in 19 countries of the South and Eastern European Region: survey results.
Giżewska M; MacDonald A; Bélanger-Quintana A; Burlina A; Cleary M; Coşkun T; Feillet F; Muntau AC; Trefz FK; van Spronsen FJ; Blau N
Eur J Pediatr; 2016 Feb; 175(2):261-72. PubMed ID: 26350228
[TBL] [Abstract][Full Text] [Related]
53. Undiagnosed maternal phenylketonuria: own clinical experience and literature review.
Bouchlariotou S; Tsikouras P; Maroulis G
J Matern Fetal Neonatal Med; 2009 Oct; 22(10):943-8. PubMed ID: 19557660
[TBL] [Abstract][Full Text] [Related]
54. Neonatal screening for congenital hypothyroidism and phenylketonuria in China.
Zhan JY; Qin YF; Zhao ZY
World J Pediatr; 2009 May; 5(2):136-9. PubMed ID: 19718537
[TBL] [Abstract][Full Text] [Related]
55. Determination of phenylalanine and tyrosine in dried blood specimens by ion-exchange chromatography using the Hitachi L-8800 analyzer.
Allard P; Cowell LD; Zytkovicz TH; Korson MS; Ampola MG
Clin Biochem; 2004 Oct; 37(10):857-62. PubMed ID: 15369715
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of effectiveness and outcome of PKU screening and management in the State of Sergipe, Brazil.
Ramalho AR; Ramalho RJ; Oliveira CR; Magalhães MM; Santos EG; Sarmento PM; Matos DO; Oliveira MC; Oliveira AL; Aguiar-Oliveira MH
Arq Bras Endocrinol Metabol; 2014 Feb; 58(1):62-7. PubMed ID: 24728166
[TBL] [Abstract][Full Text] [Related]
57. Gas chromatography-mass spectrometry method for determination of phenylalanine and tyrosine in neonatal blood spots.
Deng C; Deng Y; Wang B; Yang X
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Nov; 780(2):407-13. PubMed ID: 12401368
[TBL] [Abstract][Full Text] [Related]
58. Incidence of Neonatal Hyperphenylalaninemia Based on High-performance Liquid Chromatography Confirmatory Technique in Mazandaran Province, Northern Iran (2007-2015).
Abbaskhanian A; Zamanfar D; Afshar P; Asadpoor E; Rouhanizadeh H; Jafarnia A; Shokzadeh M
Int J Prev Med; 2017; 8():93. PubMed ID: 29184644
[TBL] [Abstract][Full Text] [Related]
59. [Differential diagnosis and therapy of various forms of hyperphenylalaninemia: facts and fiction].
Endres W
Wien Klin Wochenschr; 1992; 104(16):503-9. PubMed ID: 1413808
[TBL] [Abstract][Full Text] [Related]
60. Newborn screening of phenylketonuria using direct analysis in real time (DART) mass spectrometry.
Wang C; Zhu H; Cai Z; Song F; Liu Z; Liu S
Anal Bioanal Chem; 2013 Apr; 405(10):3159-64. PubMed ID: 23397086
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
